These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 17162143)

  • 41. [The prognostic significance of microalbuminuria in cardiovascular events].
    Piotrowska-Olczak A
    Pol Merkur Lekarski; 2004 Apr; 16(94):381-4. PubMed ID: 15517939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of microalbuminuria in the general population.
    Metcalf PA; Scragg RK
    J Diabetes Complications; 1994; 8(3):157-63. PubMed ID: 8086651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of commonly used assays for the detection of microalbuminuria.
    Busby DE; Bakris GL
    J Clin Hypertens (Greenwich); 2004 Nov; 6(11 Suppl 3):8-12. PubMed ID: 15538105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Albumin-like material in urine.
    Comper WD; Osicka TM
    Kidney Int Suppl; 2004 Nov; (92):S65-6. PubMed ID: 15485422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inclusion of albuminuria in hypertension and heart guidelines.
    Bakris G
    Kidney Int Suppl; 2004 Nov; (92):S124-5. PubMed ID: 15485406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Framingham score and microalbuminuria: combined future targets for primary prevention?
    Asselbergs FW; Hillege HL; van Gilst WH
    Kidney Int Suppl; 2004 Nov; (92):S111-4. PubMed ID: 15485402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    McQueen MJ; Gerstein HC; Pogue J; Mann JF; Yusuf S
    Am J Kidney Dis; 2006 Dec; 48(6):889-96. PubMed ID: 17162143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease.
    Mann JF; Yi QL; Gerstein HC
    Kidney Int Suppl; 2004 Nov; (92):S59-62. PubMed ID: 15485420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
    Bakris GL; Kuritzky L
    Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria.
    Pontremoli R; Leoncini G; Viazzi F; Ratto E; Vaccaro V; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S112-4. PubMed ID: 16565232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.